Leclercia adecarboxylata is a bacterium that is part of the human microbiota, but can also be found in different environments, such as water, food and animals. Although not very associated with diseases, some cases of Leclercia adecarboxylata have been registered in hospitals, mainly in newborns admitted to the Neonatal Intensive Care Unit, due to parenteral nutrition, which can be isolated in the blood.
Infection by Leclercia adecarboxylata is more frequent in immunocompromised patients, who are those who have changes in the immune system, however there are already cases of isolation of this bacterium in people who do not have any impairment of the immune system.
Risk factors for Leclercia adecarboxylata infection
Infection by Leclercia adecarboxylata is more common to happen in people who have weakened immune systems, such as newborns or people who are hospitalized for a long period, for example. In addition, there is an increased risk of infection in people who are undergoing parenteral nutrition, use a urinary catheter, have central venous access or are under mechanical ventilation.
In people with an efficient immune system, Leclercia adecarboxylata is usually identified together with other microorganisms, not receiving the appropriate treatment. However, when the immune system is weakened, it is more common for the bacteria to be identified separately in the blood, and it is essential to carry out the appropriate treatment. Understand how the diagnosis of blood infection is made.
How the treatment is done
The treatment for infection by Leclercia adecarboxylata is simple, since this bacterium has shown a lot of sensitivity to antibiotics. Therefore, according to the person's clinical condition and degree of immune system impairment, the doctor may indicate the use of Gentamycin, Ceftazidime or Glycopeptides, such as Vancomycin or Teicoplanin, for example.
Although most isolates of Leclercia adecarboxylata are sensitive to antibiotics, strains resistant to beta-lactam antibiotics are already being verified, since they are capable of producing enzymes that prevent the action of these antibiotics, which can make treatment difficult in some situations..
